Ozzinvestor Hot Penny Stock Picks

Ozzinvestor.com is a Melbourne based Penny Stock Website that has developed world wide penny stock resources to drive your share portfolio to profits on U.S, European and Australian markets. Ozzinvestor Hot Penny Stock picks has resourced all the top Penny Stock picks and taken the hours of research out of getting the best Penny Stocks.

Penny Stocks list on Ozzinvestor gives you the Penny Stock Picks from the best Penny Stock picks FREE. Penny Stock picks are available now with your once only subscription along with the downloadable software that puts you in the stocks information seat. In a day you can gain 50%-100%and more.

There are stock picks coming in daily from the best in the business, Ozzinvestor use these and in the last 5 days stocks such as BIEL, SSHO and others have returned up to 29%. There is access to these sites when you subscribe.

The software you download will give you every conceivable information and reasons to pick that stock, and make a valued decision.

Hot Penny Stocks are those shares that trade from .001 of a penny to $10.00. They currently trade on a more volatile platform than other investments, yet have tremendous reward potential. Some stocks have gone from 25 cents to $10.00.

Hot Penny Stocks like any other stocks contain an element of risk but it does not cost as much to buy more shares so almost anybody who is interested can be a player.

Penny Stocks give the average person a chance to get hold of a significant number of shares without having to take out a second mortgage.

How to earn from Hot Penny Stocks?

For example, if Penny Stocks are selling for 50 cents a share then you can easily buy 1000 shares for just $500. If the value of the Hot Penny Stocks go up just 25 cents then you make a 50% return resting on the investment and $500 might buy you only a few shares of better-known premium stocks.

Here the point being that you shouldn’t ever in a million years invest more than you can most defiantly manage to pay for to lose in any type of a stock. But with Penny Stocks you can most defiantly buy more shares for even less.

Though Penny Stocks are riskier than average investments, but they tend to have tremendous reward potentials. In fact, from resources within the past, Hot Penny Stocks had a bad name because of the risk involved and the lack of information about the companies.

Investors are quickly learning that Penny Stocks are representing small companies across America that are growing.

Take the last weeks stock picks, let’s have a look.

DRYS Dryships are up 44% in the last 20 days.

BIEL are up 414% in the last 20 days, a pick from our sources.

SSHO are up 13% in the last 4 days.

CERS up 45% in the last 2 days.

So you can’t make a little money from the picks that come through, all the resources and direct floor information is available with the software direct to give you all of this.

This is the best $30 you will spend, and if you need some tips on how to do this email David at ozzinvestor and he will guide you.

Sign up today and get started on this easy money making share system.

Ozzinvestor.com is a Melbourne based Penny Stock Website that has developed world wide penny stock resources to drive your share portfolio to profits on U.S, European and Australian markets. Ozzinvestor Hot Penny Stock picks has resourced all the top Penny Stock picks and taken the hours of research out of getting the best Penny Stocks.

Penny Stocks fee list on Ozzinvestor gives you the Penny Stock Picks from the best Penny Stock picks FREE. Ten hottest Penny Stocks right now, you need to attack these and jump on quickly. In a day you can gain 50%-100%and more.

Ten hottest penny Stocks right now

Penny stocks free list best Penny Stocks buy penny stocks online daily Penny Stock picks free

Hot Penny Stocks are those shares that trade from .001 of a penny to $5.00. They currently are traded in decimals and are much more risky than other investments, yet have tremendous reward potential. Some stocks have gone from 25 cents to $20.00, while others have become worthless too.

The stocks have traded as Over The Counter Stocks and are listed on the Over The Counter Bulletin Board also.

Hot Penny Stocks like any other stocks contain an element of risk but it does not cost as much to buy more shares so almost anybody who is interested can be a player.

Amid prices starting at under a dollar a share, Penny Stocks give the average person a chance to get hold of a significant number of shares without having to take out a second mortgage.

How to earn from Hot Penny Stocks?

For example, if Penny Stocks are selling for 50 cents a share then you can easily buy 1000 shares for just $500. If the value of the Hot Penny Stocks go up just 25 cents then you make a 50% return resting on the investment and $500 might buy you only a few shares of better-known premium stocks.

Here the point being that you shouldn’t ever in a million years invest more than you can most defiantly manage to pay for to lose in any type of a stock. But with Penny Stocks you can most defiantly buy more shares for even less.

Though Penny Stocks are riskier than average investments, but they tend to have tremendous reward potentials. In fact, from resources within the past, Hot Penny Stocks had a bad name because of the risk involved and the lack of information about the companies.

Nowadays, investors are quickly learning that Penny Stocks are representing all the small companies across America, that are brilliant and are yet to grow or are to be discovered. An established company has plummeted in value to the point where it’s stock is now worth only pennies a share.

HotOtc.com – CTHP and more about Cancer

More on CTHP

Remember to always do your own research.

Over the past 25 years, diagnoses of Leukemia and Lymphoma have increased by 88% and 87% respectively.

1 out of 78 men and women will be diagnosed with leukemia during their lifetime.

Imagine yourself sitting in a crowded movie theater watching a movie.

Most likely someone in that theater is going to have leukemia in their life. Will it be you? Will it be your wife or husband sitting next to you? Maybe your child?

Terrifying, I know! This is why we need to look at CTHP!!!

CTHP’s first investment, NanoTherapies LLC, has sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia).

The acquisition of a 25% stake in NanoTherapies is the first acquisition completed by CTHP.

CTHP sees NanoTherapies as a very promising investment and so do I.

NanoTherapies’ products introduce disruptive technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles.

These particles, about 350 times smaller than a human cell, provide both a safe and effective way to transport drugs and imaging materials into diseased cells.

The compatibility of the calcium phosphate nanoparticle with the bio-mechanics of the human body makes it unique for application in the treatment of diseases.

Calcium phosphate is a major component of bones, it clears the kidneys and liver without impact, it exits the body via the colon, and its chemical properties enable the nanoparticles to circulate in the bloodstream for prolonged periods yet dissolve in diseased cells, thereby releasing the drug.

CTHP President and CEO Chene Gardner stated, “The acquisition of NanoTherapies is a perfect fit for us since we not only have a reliable partner which complements our core business but we now have access to a number of innovative treatments for detecting and treating cancer through the revolutionary science of nanotechnology.”

There are many treatments out there to fight cancer, but unfortunately many of them are very harsh and cause more damage than the disease.

CTHP seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize.

The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer!

CTHP is seeking to create a footprint as a biotechnology business incubator with a specific emphasis on disruptive treatments and nanotechnology.

I don’t think many people know what nanotechnology is.

Nanotechnology deals with structures of the size 100 nanometers or smaller, and involves developing materials or devices within that size.

Click here to see a video from the National Cancer Institute that shows the potential of nanotechnology in cancer: http://www.youtube.com/watch?v=5jqQxuVncmc&feature=player_embedded

CTHP will be in a position to engage high level personnel and intellectual capital from NanoTherapies to evaluate other synergistic investment opportunities.

CTHP will then pursue the most promising and valuable technologies to reach the market expeditiously and benefit the lives of cancer patients worldwide.

CTHP realizes that drugs jacketed with calcium phosphate nanoparticles can provide cancer patients with immense benefits.

Early lab studies show a ten-fold reduction in toxicity with a seven-fold increase in effectiveness for drugs delivered using NanoTherapies’ technology.

This means dramatically reduced side-effects owing to the severe toxicity of cancer drugs and increased effectiveness because the half-life of the drug is increased from minutes to hours.

Most cancer drugs kill all the cells they contact and dissipate in less than thirty minutes.

NanoTherapies’ nanojackets encapsulate the drugs for up to thirty hours before being cleared from the body or until the nanoparticle enters a cancerous cell and release the drug.

CTHP President and CEO Chene Gardner said, “NanoTherapies’ products have immediate revenue potential. We believe with great confidence this will be a synergistic effort between our companies with immense potential to be a very successful business relationship.”

More information on CTHP is available at their website: http://www.cancer-therapeutics.com

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*********************************************************

More on CTHP

More on CTHP

Remember, you may need to call your broker if you would like to get involved with CTHP.

With so many different cancers existing in the world, it is extremely hard to find one cure for them all.

A cure would be a God send but it just seems unrealistic.

Cancer kills half a million Americans each year and costs the government more than $100 billion annually!!

CTHP is a company that I think is really worth taking a look at.

CTHP understands how important it is for us to have the most effective treatments that can attack cancer.

I believe CTHP is the future of cancer therapy!

There are many treatments out there to fight cancer, but unfortunately many of them are very harsh and cause more damage than the disease.

CTHP seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize.

The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer!

CTHP’s first investment under this strategy is NanoTherapies LLC.

The acquisition of a 25% stake in NanoTherapies is the first acquisition completed by CTHP.

Nano’s products introduce disruptive technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles.

CTHP could become a huge player in the cancer treatment sector being involved with a company like NanoTherapies!

These particles, about 350 times smaller than a human cell, provide both a safe and effective way to transport drugs and imaging materials into diseased cells.

Calcium phosphate is a major component of bones, it clears the kidneys and liver without impact, it exits the body via the colon, and its chemical properties enable the nanoparticles to circulate in the bloodstream for prolonged periods yet dissolve in diseased cells, thereby releasing the drug.

The compatibility of the calcium phosphate nanoparticle with the biomechanics of the human body makes it unique for application in the treatment of diseases.

CTHP President and CEO Chene Gardner said, “‘NanoTherapies’ products have immediate revenue potential. We believe with great confidence this will be a synergistic effort between our companies with immense potential to be a very successful business relationship.”

Patient benefits from drugs jacketed with calcium phosphate nanoparticles are immense.

Early lab studies show a ten-fold reduction in toxicity with a seven-fold increase in effectiveness for drugs delivered using NT’s technology.

CTHP knows that one of the most common forms of cancer is Leukemia.

Leukemia kills more children between the ages of 0 and 14 than any other disease!

It also strikes 10 times as many adults as it does children!

NanoTherapies has sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia).

CTHP will be in a position to engage high level personnel and intellectual capital from NanoTherapies to evaluate other synergistic investment opportunities.

CTHP will then pursue the most promising and valuable technologies to reach the market expeditiously and benefit the lives of cancer patients worldwide.

CTHP President and CEO Chene Gardner stated, “We are committed to developing key partnerships with companies who are some of the foremost innovators in the area of cancer treatment.”

Cancer treatment is one of the most important things we should be investing money into. Cancer can happen to us or a member of our families at any given moment.

Keep your eyes on CTHP.

For more information on CTHP, visit their website at: http://www.cancer-therapeutics.com

Please do your due diligence.

 
*************************************************

HotOtc.com – CTHP the next hot bio company?

Watch List for Tuesday 6-9-2009

My new big pick is CTHP

Some online brokers require you to call in your trade, I believe this slows down the impulsive trader that does no research. If you want to get involved with CTHP you might just have to call in your order.

As you saw the examples in my previous emails, many bio companies are blowing up there’s no other way to say it.

What makes CTHP so unique is that they are a business incubator, with a specific emphasis on disruptive treatments and nanotechnology. This mean CTHP will provide and partner with existing biotech companies and guide and fund them to get their products to market.

This ultimately means CTHP could develop a very big portfolio of cancer treatments and have interest in a broad number of companies.

If any of these treatments hit, CTHP could explode! Are bio stocks risky? Sure, can the returns be huge? Extremely huge!

CTHP announced last week it has completed a formal agreement to acquire a minority ownership share of NanoTherapies, LLC.

NanoTherapies develops life-changing therapies for cancer treatment based on an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications.

The acquisition of a 25% stake in NanoTherapies is the first acquisition completed by CTHP

Cancer is a very serious issues it touches everyone in some way.

NanoTherapies’ products introduce disruptive technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles. These particles, about 350 times smaller than a human cell, provide both a safe and effective way to transport drugs and imaging materials into diseased cells.

I’m going to get into the details about how this all works because it’s very complicated but you can read about it here:

http://www.nano-therapies.com

Put CTHP on your watch list, since it’s be slowly moving up something may be brewing. Always do you own research.

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*********************************************************

StockEgg.com – Pharmaceuticals are exploding, CTHP could be next!!

Special Alert ? CTHP

If you have been paying attention to drugs and pharmaceutical stocks, they have been exploding over night!! Some have gained 100%-400% in less than a week.

DNDN probably the most popular bio stock has for many times gone from under $4 to over $23 making many people extremely wealthy.

Could CTHP be the next one? It has come to my attention that you may need to call your broker if you want to get involved with CTHP.

CTHP is in the business of saving lives, that’s why I’m so excited about this one.

This year along over half million people are expected to die from cancer. Cancer is the second most common cause of death in the US, exceeded only by heart disease.

CTHP is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize.

The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. CTHP seeks partners to co-develop drugs in various stages in our pipeline.

CTHP just recently announced it has completed a formal agreement to acquire a minority ownership share of NanoTherapies, LLC.

NanoTherapies develops life-changing therapies for cancer treatment based on an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications.

After looking at the chart on CTHP, it looks like it’s ready to move higher. Once it catches the attention of savvy investors, we could see CTHP trading much higher.

Start your research on CTHP now, consult with a professional, access the risk and know that small caps are inherently risky.

 
*************************************************

HotOtc.com – Watch List for Tuesday – CTHP

Watch List for Tuesday 6-9-2009

My new big pick is CTHP

First off, it has come to my attention that CTHP may have some trouble trading with certain online brokers so you may have to call in your order if you wish to get involved. Before you even do that remember to always do your own research, consult with a professional, access the risk and know that penny stocks are inherently risky.

If you haven’t noticed by know all the pharma/bio stock have been blowing up.

These are not your typical 10% a day gains but gains that are 100%-500% in just 1-4 days.

Example of other biotech competitors that have exploded:

MBRX up 119% on Monday
AGEN from $.54 to over $2.50 in the last month
BTIM from $1.60 to $2.8 in a month
HGSI from .50 to over $3 in 3 months

This industry has a tendency to be very explosive as a cure or FDA decision could send a company into the stratosphere.

DNDN probably the most popular bio stock has for many times gone from under $5 to over $23 making many people extremely wealthy.

CTHP has been slowly creeping up for the last week, so put it on your watch list incase it breaks out!!

Chart: http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=cthp&sid=0&o_symb=cthp&freq=7&time=3

CTHP is a business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize. The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. CTHP seeks partners to co-develop drugs in various stages in the company’s pipeline

Start your research at: http://www.cancer-therapeutics.com

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*********************************************************

StockEgg.com – Mid Day Alert 6-8-2009

Mid Day Alert 6-8-2009
 

GMGMQ – Trade Alert
http://www.chartspread.com/stockcharts.php/?ticker=gmgmq
General Motors Corporation and its subsidiaries engage in the development, production, and marketing of cars, trucks, and related parts worldwide.

HYGN – Volume Alert
http://www.chartspread.com/stockcharts.php/?ticker=hygn
Hydrogenetics, Inc. engages in acquiring and operating businesses in the alternative energy sector, as well as in entertainment field.

ARNA – Break Out
http://www.chartspread.com/stockcharts.php/?ticker=arna
Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
 

 
*************************************************

New Stock Alert – TEMN

Having trouble viewing this email?
Click here
http://campaign.constantcontact.com/render?v=001In1Q8KG8QTP8TvDZLF5oyNVjzt0iZqDBdswN3xjw_b5ROZqV15DnOcL7Ad6CprylTERzx-W9nOn8FSIYEjQpbDjQmcBbYVSN1BeVh1dVKthZpJJhefDUZA%3D%3D
Stock Alert for Monday, June 8th, 2009

OUR NEWEST STOCK ALERT IS TEAM NATION HOLDING CORP. (TEMN)

TEMN is a relatively newly issued stock. Low float could mean an explosion in stock price. Could be a double, triple, quadruple +

Team Nation Holding Corp. was incorporated as Suncross Exploration Corporation in Nevada on November 16, 2004. Team is a management and services company deals in distressed asset acquisition, fund management, management solutions for title companies and title production services. The company leverages its business relationships, experience and analytics to analyze, evaluate, and acquire distressed security instruments, bonds, REO and non-performing notes at discounts from illiquid institutions and banks. The company also focuses on counter-cyclical growth to acquire, manage and consult for title, escrow, mortgage, real estate and REO companies.

The Company”s core business is the generation of private placement funds for investment into distressed assets, particularly performing mortgage-backed securities rated BBB. Team and its partner ABS Investment Group are responsible for analyzing over 100 bonds submitted to it daily from troubled institutions and banks. Team currently holds contracts to manage all operations of two emerging title companies operating in Southern California. It provides management, title plant and production services, customer service, sales and marketing support, HR administration, IT administration and accounting services to both companies in exchange for fees and a percentage of net profits of the operations

TEMN – http://finance.yahoo.com/q?s=TEMN.OB

************************************************************

Be on the watch for a slew of economic news and financial data that is due out this week. On the docket for this week includes:

Monday: As a result of the government’s ?stress tests?, 10 banks were told to raise additional funds. These banks must submit detailed plans on Monday June, 08.

Already, the banks have managed to raise a substantial portion of the collective $75 billion, with Bank of America (BAC: NYSE) and Morgan Stanley (MS: NYSE) among the banks that have already met or exceeded the requirements.

General Motors bankruptcy means its being removed from the Dow Jones industrial average, come Monday. It will be replaced by Cisco Systems (CSCO: NASDAQ).

Tuesday: The government’s April wholesale inventories report is due in the morning.

In Washington, the Joint Economic Committee will further examine the bank bailout program, the House Financial Services Committee is holding a hearing about regulating derivatives and the Senate Energy Committee will discuss energy legislation.

Wednesday: The Census Bureau will release the April trade balance in the morning.

The weekly crude oil inventories report from the Energy Information Administration is also due in the morning, while the May Treasury budget is due in the afternoon.

The Federal Reserves ?beige book? reading on economic activity in the afternoon.

Thursday: May retail sales report.

April business inventories from the Census Bureau.

The weekly jobless claims report from the Labor Department.

May foreclosure report from industry tracker RealtyTrac.

Friday: May import and export prices are due from the Labor Department.

June consumer sentiment index is due from the University of Michigan.

The G8 finance ministers are meeting in Rome Friday and Saturday. Treasury Secretary Timothy Geithner is expected to speak Friday.

+++++++++++++++++++++++++++++++++

Important Disclaimer:
OTCStockexchange.com (who along with its affiliates, subsidiaries, officers, directors, representatives and agents is collectively referred to as “OTCS”) maintains this website as a service to its customers, who have paid for the publication of the materials regarding their respective company or business. By using this website, you agree to the following terms of use, which OTCS may unilaterally change at any time. OTCS is not a Registered Investment Advisor or a Broker/Dealer.

No Investment Advice or Recommendation Made by OTCS:
The advertisements and materials relating to OTCS’s respective customers are not intended directly or indirectly provide advice as to the advisability of investing in, purchasing, holding or selling such securities. Instead OTCS’s customers have prepared and paid for the advertising; and the publications are not endorsements, recommendations, analysis or advisors of any nature by OTCS. OTCS does not endorse any opinions or recommendations regarding the materials advertised, nor does it give tax or investment advice or advocate the purchase or sale of any security or investment. All information provided on the OTCS website pertaining to investing, stocks, securities must be understood as information provided and not investment advice.

No Representation as to Content of Advertisement:
In preparing this publication, OTCS has relied upon information supplied by its customers, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, OTCS and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. OTCS is not responsible for any claims made by the companies advertised herein. BY ACCESSING THIS WEBSITE, YOU AGREE THAT THE INFORMATION PROVIDED IS “AS IS” AND WITHOUT WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION CURRENTNESS OR RELIABILITY OF THE CONTENT OF THE ADVERTISEMENTS MAINTAINED ON THIS WEBITE; AND WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. OTCS shall not be liable for any damage or costs arising out of or in any way connected with your use of the materials or advertisements provided or accessed through this website.

No Offer of Securities:
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead OTCS strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. OTCS does not offer such advice or analysis, and OTCS further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

Compensation
OTCS has been compensated by one or more third parties or purchased shares in the open market on behalf of the companies listed herein. Affiliates of the publisher for OTCS have received a fee of 450,000 shares of Team Nation Holding Corp. (TEMN) from a third party for this investment opinion feature. OTCS intends on selling these shares. OTCS intends on selling these shares. OTCS and its owners, affiliates, subsidiaries, officers, directors, representatives and agents may at time hold positions in securities mentioned on OTCS’s website, and may make purchases or sales in such securities featured on OTCS’s website. This compensation should be viewed as a potential conflict of interest. Furthermore, OTCS, or its owners, affiliates, subsidiaries, officers, directors, representatives and agents may have financial positions in featured companies. OTCS and its owners, affiliates, subsidiaries, officers, directors, representatives and agents may or may not increase or decrease its ownership in featured companies at any time before, during, or after distribution of information. OTCS and its owners, affiliates, subsidiaries, officers, directors, representatives and agents may profit in the event the shares of the company featured by OTCS increase in value. These positions may be liquidated from time to time even after OTCS has made positive comments regarding the company.

Buying and Selling of Shares:
OTCS intends to sell its shares in the event the shares rise in value. OTCS may sell its shares for less than target prices given in opinions. OTCS’s affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. If you have any questions you can email us at info@OTCStockexchange.com.

Public Filings:
OTCS urges its readers who are considering an investment in a specific company to check the company’s filings with the Securities and Exchange Commission (”SEC”) on the SEC’s Edgar Website located at http://www.sec.gov.

No Liability Relating to External Links:
This website contains links to other World Wide Web Internet sites, and OTCS is not responsible for the availability of these outside resources, or their contents. OTCS does not endorse, nor is it responsible for any of the contents, advertising products or other materials.

Safe Harbor for Forward-Looking Statements:
Information presented on the OTCS website contains “forward looking statements” within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.

Forward email
http://ui.constantcontact.com/sa/fwtf.jsp?m=1101109653331&ea=wpblog%40ozzinvestor.com&a=1102604014212

This email was sent to wpblog@ozzinvestor.com by info@otcstockexchange.com.

Update Profile/Email Address
http://visitor.constantcontact.com/d.jsp?p=oo&v=001JLLQ8jUAYdT3fkg5pV_KiO0A5RHRlfQLC-7lE4cQETZLkzPPYz5K-7u-6iuUw7G8laSE4O4RQ1dK0ViR6TEmew%3D%3D

Instant removal with SafeUnsubscribe(TM)
http://visitor.constantcontact.com/d.jsp?p=un&v=001JLLQ8jUAYdT3fkg5pV_KiO0A5RHRlfQLC-7lE4cQETZLkzPPYz5K-7u-6iuUw7G8laSE4O4RQ1dK0ViR6TEmew%3D%3D

Privacy Policy:
http://ui.constantcontact.com/roving/CCPrivacyPolicy.jsp

Email Marketing by
Constant Contact(R)
www.constantcontact.com

Otcstockexchange.com | 106 Cobblestone Court Drive #181 | Victor | NY | 14564

HotOtc.com – DYAP might rally big, here is why!

More on DYAP

DYAP is very thin right now that means it could be very volatile, it could make huge swings up or down. Put it on your watch list incase it starts rally big.

Going green has become a huge movement in our society today!

I believe the future is going to be very bountiful in profits for green companies like DYAP.

DYAP is focused on becoming a leading channel for the supply of Kenaf.

Companies like DYAP and Kenaf could save many lives by halting global warming.

Researchers have suggested that Kenaf may offer the extraordinary capacity to absorb and store huge quantities of carbon dioxide, the gas most associated with the adverse effects of global warming.

Kenaf has high CO2 absorption capacity. One ton of Kenaf absorbs 1.5 tons of CO2, thereby helping to directly and effectively cope with global warming.

DYAP is planning to bring order to the Kenaf supply chain, primarily by operating as a bridge between:

a) Farmers ? planting and harvesting Kenaf.
b) Manufacturers ? which use Kenaf in the production of bioplastics, paper and other materials/products.
Kenaf is being viewed increasingly as a sustainable, environmentally friendly alternative to various petroleum based synthetic raw materials.

Major corporations including Toyota, BMW, Mercedes, NEC and others are making increasing use of Kenaf based materials and are committed to their growth!

DYAP knows that Kenaf has a major advantage compared to other trees.

It needs only a short growing period and grows faster than other trees. Whereas other crop sources, such as Southern pine trees, take up to 40 years to reach harvestable size, Kenaf reaches a height of 4 to 5 meters within 3-4 months.

Kenaf grows 3 to 5 times faster than poplar, and up to 3 times faster than reed and bamboo!

DYAP could see considerable profits in the paper industry.

Kenaf is widely considered one of the most promising alternatives to virgin soft and hard woods for paper production.

In recent years a wide range of new applications have emerged with kenaf proving to be an excellent source of pulp for paper production In 1960, the USDA surveyed more than 500 plants and selected kenaf as the most promising source of “tree-free” newsprint Paper is a massive global industry. The U.S. forest and paper industry is the world’s largest by far, representing 8% of total US manufacturing output with annual sales of about $240 billion!

DYAP also knows that electronics benefit from the use of Kenaf too.

Kenaf has been integrated into the product lines of electronics companies such as NEC, Panasonic and others!

Panasonic has set up a plant in Malaysia to manufacture Kenaf fibre boards and export them to Japan.

DYAP’s operations will be centered on China which is one of the world’s largest producers of Kenaf and has a vast manufacturing base, including many factories which are already using Kenaf in their production.

The current annual sales value of Kenaf output in China is estimated at about $630 million.

DYAP expects that total to reach almost $890 million in the next five years!

DYAP is forecasting that by 2013 it will be the channel for the supply of about 76,000 tons of kenaf, representing market penetration in China of 6%, with a gross sales value of at least $53 million!

There are several companies around the world engaged in the trading of Kenaf but DYAP has not identified another company with a similar approach to the market.

DYAP’s approach is to:

a) focus on production in a selected territory, based on in-depth market research;
b) provide extensive added value to the farmer through technological support to obtain increased yields;
c) utilize existing business network to match supply and demand on a back to back basis, thereby overcoming the critical supply problems.

DYAP’s line of business is even being supported by governments and leading organizations such as the UN and CFC!

According to recent press reports, this UN organization will execute a governmental project in Malaysia to examine the industrial and commercial use of Kenaf, through funding provided by the Netherlands-based Common Funds for Commodities (CFC), of which Malaysia is a member country.

Make sure you don’t miss out on DYAP. Kenaf could become a commercial success in various industries!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*********************************************************

IXEH partnered with prisons for cheap labor!

Watch List for Monday 5-18-2009

My new big pick is IXEH.

Some of the biggest companies in the world right got big by government contracts. The government gives out contracts that could keep a company busy for a decade.

Dell Computers used this strategy to grow from a dorm room operation into a multi billion dollar business by supplying computers to government and educational institutions.

The Federal Government is out spending again and this time IXEH could benefit big!

The federal government has a mandate to increase its renewable energy use to 5% by 2010, and to 7.5% by 2013.

The “Green” revolution has just barely begun and IXEH has positioned themselves to take advantage of this.

Solar is a huge industry but it’s still in the infancy stages. One day every home and business will be equipped with solar panels.

IXEH is a very interesting company, as I started doing my research I couldn’t help but believe this is one of Wall Street’s big secret.

Let me explain the whole story.

Many people may not realized but the US Gov. is using prison labor and making lots of money. In 2007 a company called Unicor achieved $853 million in sales and $45.8 million in profits. This company is owned by the US Gov and operates off voluntary prison labor. You can learn more about Unicor at http://www.unicor.gov

Unicor has built a solar panel assembly plant at it’s prison facility in Otisville, NY. Unicor then strikes a deal with Nasdaq trading Spire for $55 Million to supply solar cells.

IXEH and Spire are working together.

After digging in deep into IXEH’s annual 10k filings I found this except:

In 2008 we (IXEH) entered into a five year sales and marketing agreement with UNICOR pursuant to which IX Energy provides sales and marketing for the UNICOR assembled solar panels at its facility in Otisville, New York and other UNICOR facilities that it may be deemed appropriate. The agreement grants us the right to market and sell to U.S. governmental customers any solar panels and related products assembled and manufactured under this agreement.

IXEH basically becomes the design, sales, and marketing arm for Unicor. Unicor generally has the inside track on contract awards for anything from the Federal Government. The Federal Government is gearing up to spend hundreds of millions on solar installations. By using the Unicor solar cells, the Federal Government is paying itself back some of the investment.

So by getting involved with IXEH you’re getting involved with Unicor which is a privately owned Gov. company that is profitable!!

The volume on IXEH has just started to pick up and I believe word is starting to spread about IXEH so do your research fast, I don’t know if IXEH will remain at these prices for long.

Visit their website at: http://www.ixenergy.com

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*********************************************************